BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34491933)

  • 41. Mild Encephalitis/Encephalopathy with Reversible Splenial Lesion Associated with Scrub Typhus in a Child: A Case Report.
    Li X; Xu D; Zhou Y; Cheng B; Wang Y; Chen Z
    Vector Borne Zoonotic Dis; 2022 Mar; 22(3):191-194. PubMed ID: 35319920
    [No Abstract]   [Full Text] [Related]  

  • 42. Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion in an Adult Patient with Influenza.
    Takatsu H; Ishimaru N; Ito M; Kinami S
    Intern Med; 2017 Nov; 56(22):3093-3095. PubMed ID: 28943565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A cohort study of mild encephalitis/encephalopathy with a reversible splenial lesion in children.
    Xue J; Zhang Y; Kang J; Duan C; Yi Z; Yang C; Li F; Liu K; Song Z
    Brain Behav; 2021 Aug; 11(8):e2306. PubMed ID: 34333864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children.
    Bektaş G; Akçay N; Boydağ K; Şevketoğlu E
    Brain Dev; 2021 Feb; 43(2):230-233. PubMed ID: 33082059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination.
    Takanashi J; Shiihara T; Hasegawa T; Takayanagi M; Hara M; Okumura A; Mizuguchi M
    J Neurol Sci; 2015 Feb; 349(1-2):226-8. PubMed ID: 25542078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A Case of Clinically Mild Encephalitis/encephalopathy with a Reversible Splenial Lesion due to Dengue Fever].
    Saito N; Kitashouji E; Kojiro M; Furumoto A; Morimoto K; Morita K; Ariyoshi K
    Kansenshogaku Zasshi; 2015 Jul; 89(4):465-9. PubMed ID: 26554222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical features of mild encephalitis/encephalopathy with a reversible splenial lesion in children].
    Liu Y; Li GM; Li SH; Wang XQ; Li SR; Zhang J; Wang HF; Pang BD; Wu JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1291-1295. PubMed ID: 27974125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in Chinese children.
    Fang Q; Chen L; Chen Q; Lin Z; Yang F
    Brain Dev; 2017 Apr; 39(4):321-326. PubMed ID: 27823946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants.
    Li XL; Han J; Yan ZR; Zhang BW; Wang HY
    J Neurovirol; 2021 Aug; 27(4):638-643. PubMed ID: 34227046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adult-onset of mild encephalitis/encephalopathy with reversible splenial lesion (MERS): case report and systematic review.
    Chiara R; Vanessa P; Nazerian P; Gabriele V; Antonio F; Luca M; Francesco A
    Neurol Sci; 2024 Jun; ():. PubMed ID: 38904900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of arterial spin labeling imaging, which contributed to the early detection of cerebellitis complicated by clinically mild encephalitis/encephalopathy with a reversible splenial lesion: Lessons from three cases.
    Nishiguchi N; Sato T; Hashimoto K; Hayashida T; Haraguchi K; Ideguchi R; Moriuchi H
    Brain Dev; 2023 Sep; 45(8):467-473. PubMed ID: 37562922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Characteristics of H1N1 Influenza A-Associated Mild Encephalopathy with Reversible Splenial Lesion: 4 Pediatric Cases.
    Li XF; Ai B; Ye JW; Tan LM; Yang HM; Fang CX; She LH; Xu Y
    Curr Med Sci; 2021 Aug; 41(4):815-820. PubMed ID: 34403107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review.
    Kubo M; Kubo K; Kobayashi KI; Komiya N
    Int J Infect Dis; 2022 Dec; 125():1-9. PubMed ID: 36122669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report.
    Kosami K; Kenzaka T; Sagara Y; Minami K; Matsumura M
    BMC Infect Dis; 2016 Apr; 16():160. PubMed ID: 27091490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversible splenial lesion syndrome associated with dengue fever: a case report.
    Sathananthasarma P; Weeratunga PN; Chang T
    BMC Res Notes; 2018 Jun; 11(1):412. PubMed ID: 29945676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical study of recurrent mild encephalitis/encephalopathy with a reversible splenial lesion in two cases.
    Xue J; Duan C; Xu G; Zhang Y; Song Z; Yi Z; Yang C; Li F; Liu K; Zhao H; Liu X
    BMC Pediatr; 2022 Jan; 22(1):17. PubMed ID: 34980057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mild encephalitis with reversible splenial (MERS) lesion syndrome due to influenza B virus.
    Vanderschueren G; Schotsmans K; Maréchal E; Crols R
    Pract Neurol; 2018 Oct; 18(5):391-392. PubMed ID: 29599175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis.
    Ka A; Britton P; Troedson C; Webster R; Procopis P; Ging J; Chua YW; Buckmaster A; Wood N; Jones C; Dale RC
    Eur J Paediatr Neurol; 2015 May; 19(3):377-82. PubMed ID: 25707871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rituximab-induced mild encephalopathy with a reversible splenial lesion syndrome (MERS): An adverse effect to add to the list.
    Thabet M; Atig A; Fathallah N; Guiga A; Ben Yahia W; Ouni B; Ghannouchi N
    Br J Clin Pharmacol; 2022 Jun; 88(6):2969-2972. PubMed ID: 34921445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mild encephalitis/encephalopathy with a reversible splenial lesion: evaluation by diffusion tensor imaging. Two case reports.
    Osuka S; Imai H; Ishikawa E; Matsushita A; Yamamoto T; Nozue H; Ohto T; Saotome K; Komatsu Y; Matsumura A
    Neurol Med Chir (Tokyo); 2010; 50(12):1118-22. PubMed ID: 21206192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.